Indian guidelines recommend routine TB screening and isoniazid for kidney transplant patients
- **The Indian Society of Organ Transplantation issued 36 consensus recommendations for managing latent tuberculosis in kidney transplantation, endorsing routine pre-transplant screening with interferon-gamma release assays.
- The panel formulated 36 consensus statements across 11 domains.
- Routine pre-transplant screening for tuberculosis infection is endorsed, with exclusion of tuberculosis disease before treatment of tuberculosis infection.
The publication
**The Indian Society of Organ Transplantation issued 36 consensus recommendations for managing latent tuberculosis in kidney transplantation, endorsing routine pre-transplant screening with interferon-gamma release assays. The panel prefers isoniazid-based treatment regimens to avoid drug interactions with calcineurin inhibitors.**
Who the findings apply to
The recommendations apply to patients undergoing kidney transplantation in India and other high-burden settings.
Why this matters
Tuberculosis remains a principal cause of morbidity and mortality after kidney transplantation across South and Southeast Asia, where infection is prevalent. India carries one-quarter of the global tuberculosis burden, yet transplant-specific guidance for high-burden settings has been scarce.
What the study found
The panel formulated 36 consensus statements across 11 domains. Routine pre-transplant screening for tuberculosis infection is endorsed, with exclusion of tuberculosis disease before treatment of tuberculosis infection.
The interferon-gamma release assay (IGRA) is preferred for screening given confounding of the tuberculin skin test by bacille Calmette-Guérin (BCG) vaccination; a Mycobacterium tuberculosis-specific antigen-based skin test (Cy-Tb) is an acceptable alternative where IGRA is unavailable or unaffordable.
Isoniazid-based regimens are preferred for treatment because rifampicin reduces calcineurin-inhibitor exposure. Isoniazid resistance, hepatotoxicity, and hepatitis C co-infection warrant individualized therapy.
What the result does not establish
The recommendations are based on a structured, evidence-informed consensus process by a multidisciplinary expert panel rather than new randomized trial data. Prospective multicenter studies are needed to validate these context-adapted recommendations.
This first India-specific, society-endorsed position statement provides context-adapted recommendations for the management of tuberculosis infection in kidney transplantation and may inform adaptation in other high-burden settings; prospective multicenter studies are needed.
Authors’ conclusion
“This first India-specific, society-endorsed position statement provides context-adapted recommendations for the management of tuberculosis infection in kidney transplantation and may inform adaptation in other high-burden settings; prospective multicenter studies are needed.”
Study and sources
Indian Society of Organ Transplantation Consensus Recommendations on Latent Tuberculosis in Kidney Transplantation
Guidelines & recommendations · Transplant infectious disease · 2026-11-05
Sources and limitations
- PubMed record PMID 42984390 (PubMed / NLM · 2026-11-06)
Related briefings
Follow ENCLAI News
Get new briefings in your news reader. No ENCLAI account needed.
The daily disease brief
One email a day: what changed in official disease reporting worldwide, with the source named for every number. Reported facts only — no forecasts and no interpretation.